Source: Annual Congress 2003 - Immunology of interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Soja, M. Wos, P. Kopinski, U. Jedynak, P. Nalepa, J. Trojan, K. Sladek (Krakow, Bydgoszcz, Poland). Clinical value of soluble interleukine-2 receptor (sIL-2R) serum level examination in the pulmonary sarcoidosis (PS). Eur Respir J 2003; 22: Suppl. 45, 1515

Member's Comments

No comment yet.

Related content which might interest you: The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 355s Year: 2006 YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Evaluation of serum concentration of soluble interleukin-2 receptors (sIL-2R) in different respiratory tract diseases Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Correlation of serum TNF-α, IL-4 and sIL-2R levels with radiologic and clinical manifestations in active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003 Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007 Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004 Clinical value of measurements of interleukin-2 soluble receptor in blood of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002 Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001 Soluble interleukin 2 receptor ( sIL-2R ) during chemotherapy of the lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002 Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 Serum levels of thrombopoietin (TPO) in patients with thrombocytosis due to lung cancer and in essential throbocythaemia (ET) Source: Eur Respir J 2001; 18: Suppl. 33, 234s Year: 2001 Role of the TNF-alpha and its 55 (sTNF-R1) and 75 (sTNF-R2) kDa receptors in bronchial hyperresponsivenes Source: Eur Respir J 2002; 20: Suppl. 38, 191s Year: 2002 The serum levels of endothelin (ET-1); an activation marker and prognostic indicator in sarcoidosis? Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Adenosine deaminase (ADA), interferon-gamma (IFN-gamma) and interleukin-18 (IL-18) levels in pleural fluid and sera for the diagnosis of tuberculous pleuritis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004